Reagents and methods for detecting HCV
US9528163B2 · kind B2 · utility
1Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2012 |
| Grant date | Dec 27, 2016 |
| Priority date | — |
| Expiry date | Feb 23, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/707
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.